|
gptkbp:instanceOf
|
gptkb:chemical_compound
|
|
gptkbp:ATCCode
|
none
|
|
gptkbp:CASNumber
|
83-74-9
|
|
gptkbp:hasBiologicalActivity
|
NMDA receptor antagonist
norepinephrine reuptake inhibitor
psychoactive
kappa-opioid receptor agonist
nicotinic acetylcholine receptor antagonist
sigma-2 receptor agonist
|
|
gptkbp:hasInChIKey
|
YZIOHPUPXKJZJG-UXBLZVDNSA-N
|
|
gptkbp:hasMolecularFormula
|
C17H19NO3
|
|
gptkbp:hasSMILES
|
COC1=CC2=C(C=C1)NC3CC4CC(C2)N(C4)C3
|
|
gptkbp:hasTherapeuticUse
|
investigational treatment for addiction
|
|
gptkbp:hasUNII
|
8H6L28F48T
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
CHEMBL29986
|
|
gptkbp:isApprovedDrug
|
no
|
|
gptkbp:isNaturalProduct
|
yes
|
|
gptkbp:IUPACName
|
gptkb:12-methoxyibogamine
|
|
gptkbp:legalStatus
|
varies by country
|
|
gptkbp:meltingPoint
|
152-153°C
|
|
gptkbp:molecularWeight
|
285.34
|
|
gptkbp:psychoactive
|
yes
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL29986
1970
CHEBI:5851
DB06147
|
|
gptkbp:routeOfAdministration
|
oral
intramuscular
|
|
gptkbp:source
|
gptkb:Tabernanthe_iboga
|
|
gptkbp:synonym
|
gptkb:Ibogaine
|
|
gptkbp:bfsParent
|
gptkb:PD98059
|
|
gptkbp:bfsLayer
|
7
|